Synopsis
Synopsis
0
CEP/COS
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Finished Drug Prices
NA
1. 2-(4-chlorobenzoylamino)-3-(2(1h)-quinolinon-4-yl)propionic Acid
2. Opc 12759
3. Opc-12759
4. Rebamipide, (+)-isomer
5. Rebamipide, (-)-isomer
1. 90098-04-7
2. Proamipide
3. Mucosta
4. 111911-87-6
5. Opc-12759
6. Rebamipide Hydrate
7. Pramipide
8. Rebator
9. 2-(4-chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl)propionic Acid
10. 139344-42-6
11. 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1h-quinolin-4-yl)propanoic Acid
12. Nsc-758955
13. 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic Acid
14. Lr583v32zr
15. Mfcd00866895
16. Ncgc00095161-01
17. 2-(4-chlorobenzamido)-3-[2(1h)-quinolinon-4-yl]propionic Acid
18. Dsstox_cid_25937
19. Dsstox_rid_81235
20. Dsstox_gsid_45937
21. Rebamipidum
22. Rebamipide [inn:jan]
23. 2-[(4-chlorobenzoyl)amino]-3-(2-hydroxyquinolin-4-yl)propanoic Acid
24. Rebamipidum [inn-latin]
25. 2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1h-quinolin-4-yl)propanoic Acid
26. Opc 12759
27. Cas-90098-04-7
28. Ccris 3585
29. Sr-05000001520
30. Unii-lr583v32zr
31. N-[(4-chlorophenyl)carbonyl]-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine
32. Dispersered72
33. 2-[(4-chlorophenyl)carbonylamino]-3-(2-oxidanylidene-1h-quinolin-4-yl)propanoic Acid
34. Rebamipide-[d4]
35. Mucosta (tn)
36. Rebamipide [mi]
37. Rebamipide [inn]
38. Rebamipide [jan]
39. Spectrum2_000039
40. Spectrum3_001959
41. Rebamipide (jp17/inn)
42. (+-)-2-(4-chlorobenzoylamino)-3-(2(1h)-quinolinon-4-yl)propionic Acid
43. (+-)-1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-4-quinolinepropanoic Acid
44. Rebamipide [who-dd]
45. Bspbio_003559
46. Gtpl871
47. Mls006011883
48. Schembl221527
49. Spectrum1505310
50. Spbio_000137
51. Rebamipide 111911-87-6
52. Chembl1697771
53. Dtxsid8045937
54. Chebi:93814
55. Kbio3_002880
56. Opc-759
57. Hms1922b20
58. Hms2090l13
59. Hms3655l11
60. Hms3714a15
61. Pharmakon1600-01505310
62. Bcp07230
63. Hy-b0360
64. Opc12759
65. Tox21_111460
66. Bbl011328
67. Ccg-39619
68. Nsc758955
69. S2032
70. Stk577121
71. Stl146407
72. 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydro-4-quinolyl)propanoic Acid
73. Akos005501649
74. Akos005721106
75. Tox21_111460_1
76. Ac-6841
77. Ac-7588
78. Db11656
79. Nsc 758955
80. 2-(4-chloro-benzoylamino)-3-(2-oxo-1,2-dihydro-quinolin-4-yl)-propionic Acid
81. 4-quinolinepropanoic Acid, 1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-, (+-)-
82. Ncgc00095161-02
83. Ncgc00095161-03
84. Ncgc00095161-04
85. Ncgc00095161-05
86. Bc164330
87. Smr003309276
88. Sy057250
89. Vs-02924
90. Sbi-0207054.p001
91. Ft-0630971
92. Ft-0655225
93. R0085
94. Sw199113-2
95. D01121
96. Ab01275518-01
97. Ab01275518_02
98. Ab01275518_03
99. 911r876
100. A802443
101. A843443
102. A900081
103. Q-201660
104. Q7301602
105. Sr-05000001520-1
106. Sr-05000001520-2
107. Sr-05000001520-3
108. Brd-a15909516-001-02-5
109. Brd-a15909516-001-03-3
110. 2-(4-chlorobenzoylamino)-3-(2-quinolon-4-yl)propionic Acid
111. 2-(4-chlorobenzoylamino)-3-[2(1h)-quinolinon-4-yl] Propionic Acid
112. 2-(4-chlorobenzoylamino)-3-[2(1h)-quinolinon-4-yl]propionic Acid
113. N-[(4-chlorophenyl)carbonyl]-3-(2-hydroxyquinolin-4-yl)alanine
114. 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoicacid
115. 2-(4-chlorobenzoylamino)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propionic Acid
116. 4-quinolinepropanoicacid,a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-
117. (+/-)-.alpha.-(p-chlorobenzamido)-1,2-dihydro-2-oxo-4-quinolinepropionic Acid
118. (+/-)-2-(4-chlorobenzoylamino)-3-(2(1h)-quinolinon-4-yl)-propionic Acid
119. 2-[(4-chlorophenyl)formamido]-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic Acid
120. 4-quinolinepropanoic Acid, .alpha.-((4-chlorobenzoyl)amino)-1,2-dihydro-2-oxo-
Molecular Weight | 370.8 g/mol |
---|---|
Molecular Formula | C19H15ClN2O4 |
XLogP3 | 2.4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 370.0720347 g/mol |
Monoisotopic Mass | 370.0720347 g/mol |
Topological Polar Surface Area | 95.5 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 598 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
A - Alimentary tract and metabolism
A02 - Drugs for acid related disorders
A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BX14 - Rebamipide
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21700
Submission : 2008-06-09
Status : Inactive
Type : II
Registration Number : 228MF10089
Registrant's Address : Jiangxi Fengxin Industrial Park, Fengxin, 330700, Jiangxi Province, P. R. China
Initial Date of Registration : 2016-04-15
Latest Date of Registration : --
NDC Package Code : 52048-1982
Start Marketing Date : 2009-07-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Hansol Pharma Co., Ltd.
Registration Date : 2024-02-22
Registration Number : 20070504-4-B-240-14(45)
Manufacturer Name : Jiangxi Synergy Pharmaceutical Co.,Ltd
Manufacturer Address : Jiangxi Fengxin Industrial Park, Fengxin 330700 Jiangxi Province, China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15001
Submission : 2000-08-10
Status : Inactive
Type : II
Registration Number : 229MF10220
Registrant's Address : Plot No. 370, Industrial Area, Phase-II, Panchkula, Haryana State, India
Initial Date of Registration : 2017-12-18
Latest Date of Registration : --
Date of Issue : 2019-08-13
Valid Till : 2022-08-12
Written Confirmation Number : WC-0171
Address of the Firm :
Registration Number : 222MF10259
Registrant's Address : 25, Barangongdan-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do Korea
Initial Date of Registration : 2010-11-18
Latest Date of Registration : --
Registrant Name : Polaris AI Pharma Co., Ltd.
Registration Date : 2012-09-27
Registration Number : 20120927-4-B-353-19
Manufacturer Name : Polaris AI Pharma Co., Ltd.
Manufacturer Address : 25 Balan Industrial Complex-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, 34 Block 10-11, Balan Industrial Complex
Registration Number : 218MF10919
Registrant's Address : 5, Soonwha-dong, Joong-Ku, Seoul. Korea
Initial Date of Registration : 2006-11-21
Latest Date of Registration : --
Registrant Name : Dongwha Pharmaceutical Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-4-B-21-09
Manufacturer Name : Dongwha Pharmaceutical Co., Ltd.
Manufacturer Address : 167, Chungju Industrial Complex 1-ro, Chungchu-si, Chungcheongbuk-do
Registration Number : 227MF10124
Registrant's Address : The Batra Center, No. 28, Sardar Patel Road, Guindy, Chennai 600 032. India
Initial Date of Registration : 2015-04-22
Latest Date of Registration : --
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?